Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of 1,2-Dihydro-2,2,4-trimethylquinoline (monomer) 10254-A

 

CASRN: 147-47-7

Formula: C12-H15-N

Synonyms/Common Names

  • Acetone anil (quinoline derivative)

Short-Term Toxicity

  • 14-Day (Topical Application)  (C60902)  Completed 
    • Rats: F344/N; Mice: B6C3F1
  • 3 weeks (Topical Application)  (C60902C)  Completed 
    • Mice: Sencar
  • 13-Week (Topical Application)  (C60902)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R - 0(U), 0(V), 5, 20, 50, 100, 200 MG/KG, M - 0(U), 0(V), 2.5, 5, 10, 20, 50 MG/KG.
  • 26 weeks (Topical Application)  (C60902C)  Completed 
    • Rats: F344/N
    • Dose: DEN (150 MG/KG), TMQ (100 MG/KG), PHENOB (500 PPM), ACETONE (0.3 ML), SALINE AND VARIOUS COMBINATIONS OF INITIATION/PROMOTION.

Long-Term Carcinogenicity

  • 2 years (Topical Application)  (C60902B)  Completed 
    • TR-456 (NIH Number: 97-3372)  (Peer Review Approval 06/20/1995A )
      Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CASRN 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Initiation/Promotion (Dermal Study) in Female Sencar Mice
    • Rats: F344/N; Mice: B6C3F1; Mice: Sencar
    • Carcinogenesis Results
      • Male Rats Some Evidence 
      • Female Rats No Evidence 
      • Male Mice No Evidence 
      • Female Mice No Evidence 
    • Dose: RATS: 0, 60, OR 100 MG/KG MICE: 0, 6, OR 10 MG/KG (CORE).
  • 2 years (Topical Application)  (C60902D)  Completed 
    • TR-456 (NIH Number: 97-3372)  (Peer Review Approval 06/20/1995A )
      Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CASRN 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Initiation/Promotion (Dermal Study) in Female Sencar Mice
    • Rats: F344/N; Mice: B6C3F1
    • Dose: RATS: 0, 36, 60, OR 100 MG/KG MICE: 0, 3.6, 6.0, OR 10.0 MG/KG.

Special Studies

  • Absorption Disposition Metabolism Elimination (Gavage; Intravenous)  (S0055)  Completed 
    • Citation: Ioannou YM, Burka LT, Sanders JM, Moorman MP, Matthews HB. Absorption, distribution, metabolism and excretion of 1,2-dihydro-2,2,4-trimethyquinioline in the male F344 rat. Drug Metabo Dispo. 1987; 15(3) 367-373. Pubmed Abstract
    • Male Rats
    • Dose: PO: 2, 20, 200 MG/KG IV: 20 MG/KG.

Genetic Toxicology

  • In Vitro Cytogenetics (CA/SCE)  (677113)  Completed 
    • Sister Chromatid Exchange Positive 
    • Chromosome Aberrations Negative 
  • Micronucleus  (A03326)  Completed 
    • Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
    • Mice: B6C3F1
    • Male Negative 
    • Female Negative (Nonstandard Protocol) 
  • Salmonella  (246341)  Completed 
    • Citation: Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen. 1987;9 Suppl 9:1-109.
    •  Negative